Article
Frank A. D'Amelio Named CFO of Pfizer
Author(s):
Frank A. D'Amelio has been named senior vice president and chief financial officer of Pfizer (New York, NY, www.pfizer.com), effective in mid-September.
Frank A. D’Amelio has been named senior vice president and chief financial officer of Pfizer (New York, NY, www.pfizer.com), effective in mid-September. D’Amelio has almost three decades of operating and financial experience at AT&T, Lucent Technologies, and Alcatel-Lucent, having served as both chief operating officer and chief financial officer at Lucent.
He succeeds Alan Levin, whose resignation from Pfizer was announced in May.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
